ArticleChemical science2026
Lan enzyme-free construction of lanthionine-bridged macrocyclic phage libraries.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phage display is a powerful technology for discovering macrocyclic peptide ligands. Many phage display-revealed peptide inhibitors comprise disulfide crosslinks, which unfortunately exhibit vulnerability to reduction and proteolysis. Lanthipeptides are a family of ribosomally synthesized peptides that harbor thioether cyclization instead of disulfides. Lanthipeptide libraries have been constructed on phage; however, only with the use of the Lan enzyme that demands specific recognition sequences. Here, we present an enzyme-free strategy for constructing lanthionine-bridged macrocyclic peptide libraries on M13 phage. Our strategy involves selective and reversible masking of the N-terminal cysteine (NCys), followed by Cys-to-Dha conversion and subsequent cyclization upon NCys deprotection. We have specifically optimized the chemistry for each step to allow easy preparation of lanthipeptide libraries. The utility of such libraries is demonstrated by panning against Keap1 as a model protein. To the best of our knowledge, this is the first demonstration of a Lan enzyme-free construction of lanthipeptide libraries on phage, which presents a significant addition to the increasing collection of cyclization chemistries that expand the chemical space of phage display.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.